Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: A 12-hour laboratory classroom study

Journal of Child and Adolescent Psychopharmacology

Volumn 18, Issue 3, 2008, Pages 248-256

  Muniz, Rafael ^a   Brams, Matthew ^b   Mao, Alice ^c   McCague, Kevin ^a   Pestreich, L ^a   Silva, Raul ^d  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Bayou City Research   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMETHYLPHENIDATE; METHYLPHENIDATE; PLACEBO;

ABDOMINAL PAIN; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; CONNERS PARENT RATING SCALE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DECREASED APPETITE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INSOMNIA; LABORATORY; LACERATION; MAJOR CLINICAL STUDY; MALE; MATHEMATICS; MORNING DOSAGE; MULTICENTER STUDY; NAUSEA; NOSE CONGESTION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK ASSESSMENT; SKAMP RATING SCALE; SOMNOLENCE; TREATMENT DURATION; VOMITING; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DRUG ADMINISTRATION; PSYCHOLOGICAL ASPECT; SCHOOL; SOCIAL ENVIRONMENT; TIME; TREATMENT OUTCOME;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHEMISTRY, PHARMACEUTICAL; CHILD; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEADACHE; HUMANS; MALE; METHYLPHENIDATE; PLACEBOS; SCHOOLS; SOCIAL ENVIRONMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 46749157212     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.0015     Document Type: Article

References (27)

1. Barkley RA: A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry 18:137-165, 1977.
2. C-DISC Interview Version 7/01 (1997) Columbia University. Conners,CK, et al 2001, AACAP poster presentation.
3. Clarke S, Heussler H, Kohn MR: Attention deficit disorder: Not just for children. Intern Med J 35:721-725, 2005.
4. Concerta® Prescribing Information. ALZA Corporation, Mountain View, CA. February 2006.
5. Conners CK, Sitarenios G, Parker JD, Epstein JN: The revised Conners' Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26:257-268, 1998.
6. DosReis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW Jr, Ellwood LC: Parental perceptions and satisfaction with stimulant medication for attention deficit/hyperactivity disorder. J Dev Behav Pediatr 24:155-162, 2003.
7. Fleiss JL: The Design and Analysis of Clinical Experiments. New York, New York, John Wiley & Sons, 1986.
8. Greenhill L, Osman BB, (eds.): Ritalin: Theory and Patient Management. New York, MaryAnn Liebert Publishers, Sections 3, 6, and 7, 1991.
9. Hugtenburg JG, Griekspoor JE, De Boer ID, Heerdink ER, Tsao YH, Egberts ACG: Methylphenidate: Use in daily practice. Pharm World Sci 27:197-201, 2005.
10. Kavale, K: The efficacy of stimulant drug treatment for hyperactivity: A meta-analysis. J Learn Disabil 15:280-289, 1982.
11. Markowitz, J.S., DeVane, C.L., Pestreich, L.K, et al. A comprehensive in vitro screening of d-, l- and dl-threo-methylphenidate: An exploratory study. J Child Adolesc Psychopharmacol 16:687-698, 2006.
12. Perwien A, Hall J, Swensen A, Swindle R: Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/ hyperactivity disorder. J Manag Care Pharm 10:122-129, 2004.
13. Silva RR, Tilker HA, Cecil JT, Kowalik S, Khetani V, Faleck H, Patin J: Open-label study of dexmethylphenidate hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 14: 555-563, 2004.
14. Silva RR, Muniz R, Pestreich L, Brams M, Mao A, Childress A. et al. Dexmethylphenidate extended-release capsules in children with Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry 47:199-208, 2008.
15. Silva RR, Muniz R, Pestreich L, Childress A, Brams M, Lopez FA., et al: Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharm 16:239-251, 2006.
16. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S: Pharmacotherapy of Attention-Deficit/ Hyperactivity Disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409-432, 1996.
17. Srinivas NR, Hubbard JW, Quinn D, Midha KK: Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder. Clin Pharmacol Ther 52:561-568, 1992.
18. Swanson JM: School-based assessments for ADD students. Irvine, CA: KC Publishing, 1992.
19. Swanson J: Compliance with stimulants for attention-deficit/hyperactivity disorder: Issues and approaches for improvement. CNS Drugs 17:117-131, 2003.
20. Swanson J.M, Kinsbourne M, Roberts W, Zucker K: Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics 61:21-29, 1978.
21. Swanson J, Wigal S, Greenhill L, Browne R, Waslik B, Lerner M, Williams L, Flynn D, Agler D, Crowley K, Fineberg E, Baren M, Cantwell DP: Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry 37:519-526, 1998a.
22. Swanson J, Wigal S, Greenhill L, Browne R, Waslik B, Lerner M, Williams L, Flynn D, Agler D, Crowley K, Fineberg E, Regino R, Baren M. Cantwell DP: Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting. Psychopharm Bull 34:55-61, 1998b.
23. Swanson J.M, Wigal SB, Wigal T, Sonuga-Barke E., Greenhill LL, Biederman J, Kollins S, Nquyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ, COMACS Study group: A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (The Comacs Study). Pediatrics 113:e206-e216, 2004.
24. Wigal S, Gupta S, Guinta D, Swanson JM: Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharm Bull 34:47-53, 1998.
25. Wigal S, Swanson JM, Feifel D, Sangal RB, Elia J, Casat CD, Zeldis JB, Conners CK: A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attentiondeficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 43:1406-1414, 2004.
26. Wilens TE, Biederman J: The stimulants. Psychiatr Clin North Am 15:191-222, 1992.
27. Wilens TE, Dodson W: A clinical perspective of attention-deficit/ hyperactivity disorder into adulthood. J Clin Psychiatry 65:1301-1313, 2004.